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P-bodies are specialized cytoplasmic compartments where translational repression and 
mRNA turnover may occur. Findings in this issue of Cell provide evidence that P-bodies 
are sites of “mRNA purgatory.” Bhattacharyya et al. (2006) reveal that normal mRNA can 
be released from P-bodies and translated into protein in response to stress. Meanwhile, 
Sheth and Parker (2006) report that aberrant mRNAs are targeted to P-bodies to undergo 
rapid decay.Messenger RNA (mRNA) molecules 
lead precarious lives. After being syn-
thesized as precursors, eukaryotic 
mRNAs run the risk of degradation, 
both before and after a series of reg-
ulated processing steps. The prob-
ability of degradation is determined 
by various RNA-interacting factors, 
which together with the mRNA form 
a complex called the messenger 
ribonucleoprotein (mRNP). The com-
position of this mRNP ultimately dic-
tates the half-life of a given mRNA.
The rate of mRNA decay is also 
influenced by translation. For exam-
ple, recognition of a premature 
termination (nonsense) codon by 
the translation machinery typically 
accelerates mRNA decay (Figure 1, 
right panel). This nonsense-medi-
ated decay (NMD) response is physi-
ologically important, because non-
sense codons lead to the generation 
of truncated proteins that are poten-
tially toxic to the cell.
The rate of mRNA translation is also 
under regulatory control. Included 
in the cell’s tool bag of translational 
regulatory factors are microRNAs 
(miRNAs), which are ?22 nucle-
otide RNAs that bind by base com-
plementarity to the 3′ untranslated 
region (UTR) of most of their targets 
(Figure 1, left panel). miRNAs usually 
act in a negative manner, repress-
ing the translation of their mRNA 
targets or triggering their decay. By 
analogy with most transcription fac-
tors, miRNAs act on a wide range of 
targets in a combinatorial manner. 1036 Cell 125, June 16, 2006 ©2006 ElseThus, a single miRNA can repress 
the translation of many mRNA tar-
gets—sometimes over 100—and a 
single mRNA may be regulated by 
many miRNAs. Current estimates 
suggest that an astounding one-
third of mammalian mRNAs are sub-
ject to miRNA-mediated translational 
repression (Pillai, 2005).
Where do translational repression 
and mRNA decay occur? Do these 
events occur at random or at specific 
sites in the cytoplasm? Although 
a complete answer has not yet 
emerged, recent evidence, includ-
ing findings in two papers in this 
issue (Bhattacharyya et al., 2006; 
Sheth and Parker, 2006), suggests 
that a significant fraction of these 
posttranscriptional events occur in 
a cytoplasmic compartment called 
a P-body (or GW body). P-bodies 
are dynamic structures discovered 
3 years ago that contain high con-
centrations of molecules involved 
in mRNA decay and translational 
repression (Liu et al., 2005). Strong 
evidence that P-bodies are sites 
of normal mRNA decay rather than 
merely storage sites for RNA decay 
factors is that they accumulate mRNA 
decay intermediates. Also, blocking 
mRNA decay events, such as decap-
ping and exoribonuclease cleavage, 
results in larger and more abundant 
P-bodies. Conversely, blocking 
deadenylation of mRNAs reduces 
the size and number of P-bodies, 
suggesting that poly (A) shortening is 
linked to their assembly or integrity. vier Inc.P-bodies are also probably sites of 
translational repression, as transla-
tionally arrested mRNAs accumulate 
in P-bodies, whereas ribosomal pro-
teins and some translation factors 
are largely absent from P-bodies. 
Furthermore, inhibitors of transla-
tional initiation increase the number 
and size of P-bodies, whereas inhibi-
tors of translational elongation (which 
trap ribosomes on mRNAs) have the 
opposite effect. Several lines of evi-
dence suggest that miRNA-medi-
ated translational repression occurs 
in P-bodies, including the finding 
that miRNA-repressed mRNAs local-
ize to P-bodies and that silencing of 
GW182, a structural component of P-
bodies, leads to loss of P-bodies and 
impairment of miRNA function (Liu et 
al., 2005).
Bhattacharyya et al. (2006) asked 
whether an mRNA that is trans-
lationally repressed can escape 
the clutches of a P-body. As an 
experimental model, these authors 
examined the mRNA encoding the 
cationic amino-acid transporter 1 
(CAT-1), which contains a 3′UTR 
that is negatively regulated by the 
miRNA miR-122 (Chang et al., 2006). 
The authors discovered that trans-
lationally repressed CAT-1 mRNA 
is localized in P-bodies. However, it 
can escape translational repression 
and P-body entrapment in response 
to amino acid starvation, oxidative 
stress, or endoplasmic reticulum 
stress (Figure 1, left panel). Interest-
ingly, both translational derepression 
Figure 1. The Active Lives of P-Bodies
(Left) Two RNA regulatory pathways converge in P-bodies. MicroRNAs are processed from primary miRNAs in the nucleus and are further cleaved 
in the cytoplasm to form an miRNA ribonucleoprotein (miRNP) complex. This complex represses the translation of specific mRNAs by base pair-
ing with their 3′UTRs. Bhattacharyya et al. (2006) provide evidence that the miRNA miR-122 represses the translation of the cationic amino acid 
transporter-1 (CAT-1) mRNA in P-bodies. Stress relieves this repression, releasing CAT-1 mRNA from P-bodies and allowing its active translation. 
The derepression of CAT-1 translation requires HuR, an RNA binding protein that interacts with AU-rich elements (AREs) in the 3′UTR of CAT-1. 
Because HuR is a nuclear-cytoplasmic shuttling protein it may be recruited to CAT-1 mRNA when it is first made in the nucleus. Alternatively, HuR 
may be recruited to CAT-1 mRNA in the cytoplasm in response to stress, as some stresses are known to mobilize HuR to the cytoplasm. 7mG is a 
specialized 5′ cap found on mRNAs, and AAA represents the polyadenosine tail found on most mRNAs.
(Right) According to Sheth and Parker (2006), P-bodies are sites where aberrant mRNAs harboring premature termination (nonsense) codons are de-
graded by an RNA surveillance pathway called nonsense-mediated decay (NMD). Recruitment of PTC-bearing mRNAs to P-bodies requires UPF1, 
an ATPase-dependent RNA helicase essential for NMD. Entry into the P-body is not sufficient for mRNA decay; also required is UPF1 ATP hydrolysis 
and ill-defined steps mediated by the NMD proteins UPF2 and UPF3. Some normal mRNAs are also present in P-bodies, where they may be stored 
as translationally repressed mRNAs. Normal mRNAs can also exit P-bodies to be translated, a process that evidence from Sheth and Parker (2006) 
indicates requires UPF1-mediated ATP hydrolysis.and P-body exit require AU-rich ele-
ments (AREs), which are present in 
the CAT-1 3′ UTR. These elements 
bind to HuR, an ARE binding protein 
(ARE-BP) of the ELAV family (Figure 
1, left panel). The authors found that 
HuR is necessary to release reporter 
mRNAs from miRNA-mediated 
translational blockade and P-body 
entrapment.
The work of Bhattacharyya et al. 
(2006) provides strong evidence that 
mammalian P-bodies are not a ter-
minal end-point for mRNAs, on the 
contrary, an mRNA in a P-body can 
return to the actively translated pool 
of mRNAs if an appropriate stimu-
lus is received (Figure 1). But what 
constitutes an appropriate stimulus? 
Which stresses elicit the response 
and which do not? What about non-
stress stimuli, such as growth sig-
nals or developmental cues? And do sequences other than those found in 
3′UTRs have a role in the response? 
On that note, sequences in the 
5′UTR of CAT-1 have been reported 
to derepress translation in response 
to amino acid starvation in cells that 
do not express miR-122 (Yaman et 
al., 2003). It is also unclear whether 
derepression of translation is a gen-
eral response to stress that extends 
to transcripts other than CAT-1 and 
to nonmammalian cells. Clearly, 
some proteins exhibit the oppo-
site response and show decreased 
expression in response to stress, 
which explains why various forms 
of stress (including glucose depriva-
tion, osmotic stress, ultraviolet light, 
and late-stage growth) are known to 
repress translation and increase the 
number of P-bodies in yeast.
Another intriguing aspect of CAT-
1 regulation is that the ARE-BP HuR Cell 125, Jparticipates in the derepression of 
CAT-1 translation and its movement 
out of P-bodies. Does HuR repel the 
miRNA complex that represses trans-
lation, or does it somehow block the 
complex from acting? HuR is rela-
tively unique among ARE-BPs in that 
it typically promotes mRNA stability 
and translation, whereas most ARE-
BPs usually have a negative effect 
on gene expression (Barreau et al., 
2005). These other ARE-BPs may 
collaborate with miRNAs to decrease 
gene expression. A recently discov-
ered example is tristetraprolin, which 
acts with miR-16 to efficiently elicit 
the decay of the mRNA encoding 
the cytokine tumor necrosis factor-α 
(Jing et al., 2005). HuR, in contrast, 
may mediate its positive effects on 
the expression of its wide range of 
mRNA targets by interfering with the 
function of miRNAs.une 16, 2006 ©2006 Elsevier Inc. 1037
Sheth and Parker (2006) focused 
their study on the role of P-bod-
ies in mRNA decay. In particular, 
they addressed whether P-bodies 
are compartments in which aber-
rant transcripts harboring nonsense 
codons are degraded by the NMD 
pathway. They obtained several lines 
of evidence that the answer is yes, at 
least in yeast (Figure 1, right panel). 
First, they found that nonsense 
codon-bearing reporter transcripts 
are localized to P-bodies. Second, 
this localization requires Upf1p, an 
RNA helicase essential for NMD. 
Third, Upf1p and two other NMD 
proteins, Upf2p and Upf3p, accumu-
late in P-bodies when the catalytic 
step of NMD is blocked. Fourth, Upf 
protein accumulation appears to be 
specific for the NMD pathway, as it 
did not occur in a mutant yeast strain 
deficient in normal mRNA decapping. 
Finally, inhibition of NMD triggered 
an increase in the size and number 
of P-bodies.
Intriguingly, Sheth and Parker 
(2006) obtained evidence that Upf1p 
has at least two distinct functions: 
it promotes mRNA entry into a P-
body, and together with Upf2p and 
Upf3p, it is necessary for the decay 
of the target mRNA once entrapped 
in the P-body (Figure 1, right panel). 
The use of an ATPase defective form 
of Upf1p was key to determining 
the second function of this protein. 
Forced expression of mutant Upf1p 
increased the size and number of P-
bodies, suggesting that ATP hydroly-
sis by Upf1p is required for the deg-
radation of nonsense codon-bearing 
transcripts in P-bodies. Remark-
ably, the ATPase-defective Upf1p 
mutant also dramatically increased 
the level of normal transcripts in P-
bodies. This suggested that normal 
transcripts enter P-bodies and that 
Upf1p ATPase hydrolysis is required 
for them to escape.
The findings of Sheth and Parker 
(2006) led them to propose a model 
in which two rounds of discrimina-
tion dictate whether a transcript is 
targeted for decay in P-bodies. The 
first round determines whether an 
mRNA enters into a P-body, and the 
second round determines whether it 1038 Cell 125, June 16, 2006 ©2006 Elsis degraded there. This two-round 
system might significantly increase 
the fidelity of RNA surveillance, 
thus ensuring that more of the aber-
rant transcripts are degraded and 
more of the normal transcripts are 
spared. Currently, it is not known 
how Upf1p directs the formation of 
yeast P-bodies: does it promote the 
entry of mRNAs into existing P-bod-
ies, or does it favor the aggrega-
tion of mRNAs such that they form 
new P-bodies? Also unclear is the 
part played by ATPase hydrolysis in 
UPF1’s second role promoting the 
degradation of aberrant transcripts 
once they are in P-bodies. In mam-
malian cells, UPF1-mediated ATP 
hydrolysis appears to also be involved 
in the later stages of NMD, as UPF1 
mutants lacking the ATPase domain 
are still able to interact with the NMD 
proteins UPF2 and UPF3 (Kashima et 
al., 2006). This ATP hydrolysis step 
might trigger mRNA decay by alter-
ing the molecular conformation of 
the mRNP complex, enabling attack 
by ribonucleases.
Several other issues about P-
bodies remain unresolved. The fac-
tors that determine whether a given 
mRNA accumulates in a P-body 
are not understood. Which pro-
teins in the mRNP dictate this deci-
sion, and how do they interact with 
the miRNAs that apparently destine 
mRNAs for P-bodies? What deter-
mines whether an mRNA is stored or 
degraded in a P-body? Does trans-
lational repression occur before or 
after P-body formation? Can only 
mRNAs that retain their 5′ cap and 
most of their polyadenosine tail leave 
P-bodies and resume translation? 
The answers to these questions will 
require using techniques to follow 
the fate of a population of mRNAs 
over time. What proportion of RNA 
decay and translational repression 
occurs in P-bodies? Clearly, some 
mRNA decay occurs elsewhere, 
because the exosome, which medi-
ates 3′-to-5′ decay of mRNA, is not 
in P-bodies. Useful tools to address 
these questions would include spe-
cific markers of both mRNA decay 
and translation in living cells to 
detect decay intermediates and pep-evier Inc.tidyl-tRNAs, respectively. Finally, 
are the functions and responses of 
P-bodies conserved across phyla? 
Like mammalian P-bodies, yeast P-
bodies can be nudged into releasing 
their mRNAs so that they can return 
to the translation pool (Brengues 
et al., 2005). NMD components are 
found in mammalian P-bodies sug-
gesting that, as in yeast, mammalian 
NMD occurs in P-bodies. It remains 
to be seen whether the mechanisms 
for translational derepression and 
NMD in P-bodies are conserved in 
different organisms.
In Shakespeare’s Macbeth, a 
series of murders prophesized by 
witches lead the anguished Lady 
Macbeth to exclaim, “What’s done 
cannot be undone.” Likewise, once 
it is defined as aberrant, an mRNA 
harboring a premature termination 
codon is apparently fated to die in P-
bodies. In contrast, normal mRNAs 
do not necessarily suffer the same 
fate, but rather, like Lazarus, they can 
escape the P-body tomb to resume 
translation.
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